Among them, a combination of four biomarkers—TNF-α, INS, AGEs, and Creatinine (Cr)—could predict the occurrence of diastolic dysfunction (DD) in patients with T2DM, with a sensitivity of approximately 79% and specificity of 100%. Here, TNF is linked to type 2 diabetes mellitus.